Hôpital Lapeyronie

Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.

• Hôpital LAPEYRONIE

  Montpellier, 34295

  2 trials

  • NCT07137598A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)

  • NCT05727371Combination of PRP and XLHA Prepared With RegenMatrix Medical Device To Treat Moderate to Severe Knee Osteoarthritis

• Lapeyronie Hospital

  Montpellier, 34090

  2 trials

  • NCT04554277Medico-economic Evaluation of Therapeutic Adaptation Guided by the Soluble Suppression of Tumorigenicity 2 (sST-2) Biomarker in the Management of Patients With Acute Heart Failure

  • NCT03768271APACHE Cohort (A Psoriatic Arthritis CoHort)

    Contact: Cédric LUKAS

• CHRU de Montpellier, Hopital Lapeyronie - Departement d'endocrinologie, Diabete, Nutrition

  Montpellier

  1 trial

  • NCT05409131Omnipod 5 System Compared to Pump Therapy

• Hôpital Lapeyronie, Service d'Immuno-Rhumatologic

  Montpellier, 34295

  1 trial

  • NCT03025308Long Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis

• Hopital Lapeyronie,Service d'Immuno Rhumatologie

  Montpellier, Occitanie 34295

  1 trial

  • NCT06723106Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)

• Hopital Lapeyronie - Service Orthopédie

  Montpellier, Occitanie 34295

  1 trial

  • NCT03396224Avenir® Cemented Hip Stem - PMCF

• Lapeyronie Hospital, Rheumatology and Immunology department

  Montpellier, 34295

  1 trial

  • NCT03401060Interest of Denosumab Treatment in Osteoporosis Associated to Systemic Mastocytosis

• Montpellier hospital Lapeyronie

  Montpellier, 34000

  1 trial

  • NCT04291573Recovering Arm Function in Chronic Post-stroke Patients Using Combined HD-tDCS and Virtual Reality Therapy

• Rheumatology Department, Lapeyronie Hospital

  Montpellier, 34295

  1 trial

  • NCT04084223JAKPOT (JAK Inhibitors and Predictors of Outcome in RheumaToid Arthritis)